BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6947956)

  • 1. [Primary structure of class II human histocompatibility antigens. 1st communication. Amino acid sequence of the N-terminal 198 residues of the beta chain of a HLA-Dw2,2;DR2,2-alloantigen (author's transl)].
    Kratzin H; Yang CY; Götz H; Pauly E; Kölbel S; Egert G; Thinnes FP; Wernet P; Altevogt P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1665-9. PubMed ID: 6947956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary structure of class II human histocompatibility antigens. 2nd Communication. Amino acid sequence of the N-terminal 179 residues of the alpha-chain of an HLA-Dw2/DR2 alloantigen (author's transl)].
    Yang C; Kratzin H; Götz H; Thinnes FP; Kruse T; Egert G; Pauly E; Kölbel S; Wernet P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1982 Jun; 363(6):671-6. PubMed ID: 6955253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary structure of human class II histocompatibility antigens (HLA-D). I. Isolation, purification and characterization of the HLA-D alpha/beta chain complex from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2, 2;DR2,2;MT1,1;DC1,1;MB1,1].
    Thinnes FP; Egert G; Götz H; Pauly E; Altevogt P; Kölbel S; Wernet P; Kratzin H; Yang C; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1277-89. PubMed ID: 6334638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary structure of human class II histocompatibility antigens (HLA-D). II. Separation of alpha from beta-chains of HLA-D from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2,2;MT1,1;DC1,1;MB1,1), and characterization of the isolated chain].
    Egert G; Thinnes FP; Götz H; Pauly E; Kratzin H; Yang CY; Kölbel S; Altevogt P; Wernet P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1291-308. PubMed ID: 6334639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary structure of human class II histocompatibility antigens 3rd communication. Amino acid sequence comparison between DR and DC subclass antigens derived from a lymphoblastoid B cell line homozygous at the HLA loci (HLA-A3,3; B7,7; Dw2,2; DR2,2: MT1,1; Dc1,1: MB1,1).
    Götz H; Kratzin H; Thinnes FP; Yang C; Kruse T; Pauly E; Kölbel S; Egert G; Wernet P; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1983 Jun; 364(6):749-55. PubMed ID: 6576979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
    Alexander S; Hubbard SC; Strominger JL
    J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
    J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial N-terminal sequence analysis of DRw53 antigens: the beta-chains of DRw53 antigens are structurally distinct from beta-chains of DR and DQ antigens.
    Obata F; Endo T; Tate G; Miyokawa N; Katagiri M; Kashiwagi N
    J Immunol; 1986 Mar; 136(6):2187-90. PubMed ID: 3456389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two-dimensional gel analyses of HLA-D region antigens by the use of monoclonal antibodies].
    Takenouchi T
    Hokkaido Igaku Zasshi; 1983 May; 58(3):279-91. PubMed ID: 6194092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extracellular region of light chains from human and murine MHC class II antigens consists of two domains.
    Kaufman JF; Strominger JL
    J Immunol; 1983 Feb; 130(2):808-17. PubMed ID: 6401306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
    Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
    J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two dimensional gel analysis of HLA-DR2 associated HLA-D clusters.
    Nakatsuji T; Moriya K; Tsuji K
    Tokai J Exp Clin Med; 1986 May; 11(2):125-31. PubMed ID: 3031855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
    Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
    J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cDNA cloning and sequencing reveals that the electrophoretically constant DR beta 2 molecules, as well as the variable DR beta 1 molecules, from HLA-DR2 subtypes have different amino acid sequences including a hypervariable region for a functionally important epitope.
    Wu SK; Yabe T; Madden M; Saunders TL; Bach FH
    J Immunol; 1987 May; 138(9):2953-9. PubMed ID: 3571980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary structural variation among serologically indistinguishable DS antigens: the MB3-bearing molecule in DR4 cells differs from the MB3-bearing molecule in DR5 cells.
    Giles RC; Hurley CK; Capra JD
    J Immunol; 1984 Jul; 133(1):1-3. PubMed ID: 6609970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactive T cell clones from unrelated individuals reveal similarities in peptide presentation between HLA-B27 and HLA-DR2.
    López D; Barber DF; Villadangos JA; López de Castro JA
    J Immunol; 1993 Apr; 150(7):2675-86. PubMed ID: 7681078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
    Khalil H; Brunet A; Thibodeau J
    J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human HLA-DR antigens are encoded by multiple beta-chain loci.
    Hurley CK; Nunez G; Winchester R; Finn OJ; Levy R; Capra JD
    J Immunol; 1982 Nov; 129(5):2103-8. PubMed ID: 6811658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.